| P2093 | author name string | Abdolmohamad Rostami | |
| | Farinaz Safavi | |
| P2860 | cites work | Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus | Q22010693 |
| | Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase | Q24336387 |
| | Granzymes: a family of lymphocyte granule serine proteases | Q24542560 |
| | IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G | Q24633495 |
| | How neutrophils kill microbes | Q24672245 |
| | Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis | Q26864089 |
| | Expanding the clinical indications for α(1)-antitrypsin therapy | Q27000764 |
| | Human and mouse proteases: a comparative genomic approach | Q28184208 |
| | Complement. First of two parts | Q28210663 |
| | Thrombin and vascular inflammation | Q28246124 |
| | Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo | Q28511351 |
| | The regulation of IL-10 production by immune cells | Q29615479 |
| | Serine protease inhibitor attenuates ovalbumin induced inflammation in mouse model of allergic airway disease | Q31075878 |
| | Proteinase 3 is an IL-32 binding protein | Q33234335 |
| | Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation | Q33762651 |
| | Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases | Q34149948 |
| | The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans | Q34193501 |
| | Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation | Q34665150 |
| | Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice | Q34876029 |
| | Matrix metalloproteinases and neuroinflammation in multiple sclerosis | Q35017633 |
| | Novel aspects and new roles for the serine protease plasmin. | Q35750284 |
| | Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor | Q35920315 |
| | Matrix metalloproteinases as modulators of inflammation | Q36449536 |
| | Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes | Q36704066 |
| | Neutrophil serine proteases fine-tune the inflammatory response | Q36737987 |
| | Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation | Q36984691 |
| | The biochemical and functional food properties of the bowman-birk inhibitor | Q37084669 |
| | Critical regulation of early Th17 cell differentiation by interleukin-1 signaling | Q37250727 |
| | Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis | Q37297572 |
| | A critical role for neutrophil elastase in experimental bullous pemphigoid | Q37302986 |
| | C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation | Q37314858 |
| | Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro | Q37528396 |
| | Bowman-Birk inhibitors from legumes and human gastrointestinal health: current status and perspectives. | Q37854782 |
| | C1-inhibitor: more than a serine protease inhibitor | Q37909227 |
| | Plasmin as a proinflammatory cell activator. | Q38007805 |
| | Matrix metalloproteinases: a review of their structure and role in systemic sclerosis | Q38024303 |
| | Matrix metalloproteinases in vascular physiology and disease | Q38034952 |
| | Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis | Q39737467 |
| | Apoptosis and lysosome membrane permeabilization induction on breast cancer cells by an anticarcinogenic Bowman-Birk protease inhibitor from Vigna unguiculata seeds. | Q39743538 |
| | Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells | Q41021328 |
| | A proteolytic activity in a human breast cancer cell line which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor | Q41435747 |
| | c-fos mRNA levels are reduced in the presence of antipain and Bowman-Birk inhibitor | Q42835020 |
| | The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases. | Q43249704 |
| | Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation | Q43252195 |
| | The neutrophil granule protein cathepsin G activates murine T lymphocytes and upregulates antigen-specific IG production in mice | Q43607450 |
| | Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells | Q43869797 |
| | Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice | Q43926011 |
| | Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors. | Q44526558 |
| | Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease | Q44807380 |
| | Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. | Q45299364 |
| | Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis | Q46245129 |
| | Thrombin regulates the function of human blood dendritic cells | Q46940799 |
| | Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators. | Q48228189 |
| | The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis | Q48293570 |
| | Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis | Q49142940 |
| | Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. | Q50335883 |
| | Nafamostat mesilate attenuates colonic inflammation and mast cell infiltration in the experimental colitis. | Q51525966 |
| | Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor. | Q53332234 |
| | Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine. | Q53506598 |
| | Interleukin-10 prevents experimental allergic encephalomyelitis in rats. | Q54205210 |
| | Protease inhibitors suppress in vitro growth of human small cell lung cancer | Q57268819 |
| | Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation | Q59189539 |
| | IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family | Q77807763 |
| | Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis | Q80435281 |
| | Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS | Q82564448 |
| | Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice | Q83710108 |
| | Serine protease inhibitor, 4-(2-aminoethyl)-benzene sulfonyl fluoride, impairs IL-12-induced activation of pSTAT4β, NFκB, and select pro-inflammatory mediators from estrogen-treated mice | Q84667672 |
| P433 | issue | 3 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 428-433 | |
| P577 | publication date | 2012-09-27 | |
| P1433 | published in | Experimental and Molecular Pathology | Q15767470 |
| P1476 | title | Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases | |
| P478 | volume | 93 | |